CIK 0000744218 · Large accelerated filer
Celldex Therapeutics, Inc.
Sign in to watch- Ticker
- CLDX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 133191702
- Phone
- 908-200-7500
- Business address
- 53 FRONTAGE ROAD, SUITE 220, HAMPTON, NJ, 08827
- Former names
- AVANT IMMUNOTHERAPEUTICS INC, T CELL SCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-06-19 | Marucci Anthony S President & CEO | Grant or award · Incentive Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2019-06-19 | MARINO JAMES J Director | Grant or award · Non-Qualified Stock Option (right to buy) | +4,500 | 4,500 | ||
| 2019-06-19 | Brownlie Keith L Director | Grant or award · Non-Qualified Stock Option (right to buy) | +4,500 | 4,500 | ||
| 2019-06-19 | CONRAD HERBERT J Director | Grant or award · Non-Qualified Stock Option (right to buy) | +4,500 | 4,500 | ||
| 2019-06-19 | PENNER HARRY JR Director | Grant or award · Non-Qualified Stock Option (right to buy) | +4,500 | 4,500 | ||
| 2019-06-19 | Shoos Karen L. Director | Grant or award · Non-Qualified Stock Option (right to buy) | +4,500 | 4,500 | ||
| 2018-12-03 | McMahon Gerald PhD Director | Shares withheld for taxes | −2,824 | $0.30 | $843 | 180,697 |
| 2018-11-01 | McMahon Gerald PhD Director | Shares withheld for taxes | −2,888 | $0.31 | $908 | 183,521 |
| 2018-10-01 | McMahon Gerald PhD Director | Shares withheld for taxes | −2,888 | $0.45 | $1K | 186,409 |
| 2018-09-04 | McMahon Gerald PhD Director | Shares withheld for taxes | −2,813 | $0.50 | $1K | 189,297 |
| 2018-08-24 | MARINO JAMES J Director | Purchase | +40,000 | $0.48 | $19K | 65,997 |
| 2018-08-01 | McMahon Gerald PhD Director | Shares withheld for taxes | −2,813 | $0.47 | $1K | 192,110 |
| 2018-07-02 | McMahon Gerald PhD Director | Shares withheld for taxes | −2,813 | $0.50 | $1K | 194,923 |
| 2018-06-15 | KELER TIBOR Executive VP & CSO | Purchase | +16,500 | $0.59 | $10K | 35,368 |
| 2018-06-13 | Heath-Chiozzi Margo SVP of Regulatory Affairs | Grant or award · Incentive Stock Option (right to buy) | +275,000 | 275,000 | ||
| 2018-06-13 | Martin Samuel Bates SVP and CFO | Grant or award · Incentive Stock Option (right to buy) | +395,000 | 395,000 | ||
| 2018-06-13 | Cavanaugh Sarah SVP of Corp Affairs & Admin. | Grant or award · Incentive Stock Option (right to buy) | +275,000 | 275,000 | ||
| 2018-06-13 | Crowley Elizabeth Sr. VP &CPDO | Grant or award · Incentive Stock Option (right to buy) | +300,000 | 300,000 | ||
| 2018-06-13 | Wright Richard M. Sr. VP & CCO | Grant or award · Incentive Stock Option (right to buy) | +275,000 | 275,000 | ||
| 2018-06-13 | PEPIN RONALD Sr. VP & CBO | Grant or award · Incentive Stock Option (right to buy) | +200,000 | 200,000 |
Page 16 of 17 · 325 trades